Drug Stocks Favored by Funds

Description:

According to Robert Holmes, "Drug stocks such as Johnson & Johnson (JNJ) and Gilead Sciences (GILD) have been beaten up in the year since the health-care reform bill was passed. That may soon change, as fund managers are pouncing on shares of undervalued companies." Here are the health-care equity picks of two fund managers and an analyst. Read more here.

>>Also: 10 Buy-Rated Stocks Under $5

>>Also: 4 Small Stocks With Buyout Rumors

Most Viewed Portfolios

View All

Articles

5 Big Financial Stocks to Boost Your Gains in September

09.16.14 | 10:05 AM

BALTIMORE (Stockpickr) -- Did you notice the subtle shift in stocks at the beginning of the summer? It was easy to miss, but grabbing hold of the n...

How to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAP

09.16.14 | 09:20 AM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter